Skip to: site menu | section menu | main content
Joseph Shemaria
Contact
Info
2029 Century Park
East
Suite 1400
map
Los Angeles, CA 90067
800-898-9555
contact@criminal
defenselawyers.com
June 4, 2007
LOCAL DOCTOR PLEADS GUILTY TO USING NON-FDA APPROVED DRUG ON PATIENTS
SACRAMENTO – United States Attorney McGregor W. Scott announced today that DR. TIMOTHY J. ROSIO, 52, of Cameron Park, pleaded guilty today before United States Magistrate Judge Kimberly J. Mueller to a two-count information charging delivery of a misbranded drug and misbranding a drug held for sale.
This case is the product of an extensive investigation by the Food and Drug Administration (“FDA”).
According to Assistant United States Attorney Michael M. Beckwith, who prosecuted the case, DR. ROSIO ordered a drug that the FDA had not approved for use in humans from Arizona-based Toxin Research International (“TRI”). The drug’s packaging, labeling, and invoices clearly stated “FOR RESEARCH PURPOSES ONLY, NOT FOR HUMAN USE.” After receiving the drug, DR. ROSIO, offered it for sale to the public under the familiar name of Botox. He administered it to at least fifteen patients, some on multiple occasions, in the form of injections, all for monetary compensation.
The defendant is scheduled to be sentenced by Judge Mueller on August 16, 2007, at 2
p.m. The maximum statutory penalty for violations of 21 U.S.C. § 331(c) and (k) is up to one year in prison, a $100,000 fine, and a one year term of supervised release on each count. However, the actual sentence will be determined at the discretion of the court after consideration
of the Federal Sentencing Guidelines, which take into account a number of variables, and any applicable statutory sentencing factors.
[ Back to top ]
Home | Selecting | Practice Areas | Credentials | Profile | Biography | Contact Us | Disclaimer | Preeminent | Code